Rocket Lab has delayed the debut of its powerful, partially reusable Neutron launcher to 2027 due to a manufacturing issue.

In response to the update, KeyBanc slashed its price target on Rocket Lab to $100 from $135, maintaining an overweight rating ...

Tiny air pockets in a carbon fiber tank dome pushed Rocket Lab’s Neutron debut into 2027. Here’s what the delay means for ...

Just in Time for 2026, Rocket Lab Won Its Biggest Contract Ever (Jan. 4, $816 million to build 18 missile defense satellites ...

Rocket Lab has shed nearly a fifth of its value in one week while sitting on a record backlog and a wall of analyst buy ...

Rocket Lab shares dropped 8.2% after the Neutron rocket's first flight slipped to 2027; Goldman Sachs and KeyBanc cut price ...

SpaceX CEO Elon Musk said competitors' future plans still lag behind Starship. Musk endorsed an X user's argument that ...

A manufacturing flaw found during production has forced Rocket Lab to push its most ambitious rocket program past a deadline ...

Rocket Lab Corp. again delayed the debut of its new, more powerful Neutron rocket, pushing the vehicle’s first flight to 2027 ...

Rocket Lab ( RKLB) shares fell 7.3% in extended trading Wednesday after the space launch company pushed the inaugural flight ...

Shares of aerospace and defense company Rocket Lab (NASDAQ:RKLB) fell 9.8% in the morning session after the company announced ...

Neutron delay to 2027, dilution risks, and Iridium deal—yet strong margins, FCF growth, and defense tailwinds. See more here.